Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
JAMA Network Open|March 20, 2024
Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic ReviewAlexandra Griessbach, Christof Manuel Schönenberger, Ala Taji Heravi, et al.Journal of Clinical Epidemiology|July 20, 2024
Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping reviewAlain Amstutz, Christof M Schönenberger, Benjamin Speich, et al.Journal of Clinical Epidemiology|June 13, 2025
Public availability of randomized clinical trial protocols: A repeated meta-research studyChristof Manuel Schönenberger, Malena Chiaborelli, Ala Taji Heravi, et al.AIDS (London, England)|October 13, 2023
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, et al.Journal of Clinical Epidemiology|June 2, 2022
A meta-research study of randomized controlled trials found infrequent and delayed availability of protocolsChristof Manuel Schönenberger, Alexandra Griessbach, Ala Taji Heravi, et al.Journal of Clinical Epidemiology|May 11, 2025
Meta-research on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting biasAla Taji Heravi, Dmitry Gryaznov, Jason W Busse, et al.Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.Pageof 3